氯吡格雷/阿司匹林单片复方制剂抗血小板治疗中国专家共识

2021-06-30 中国医师协会心血管内科医师分会中国介入心脏病学杂志.2021.29(6):306-312.

双联抗血小板治疗（DAPT）一直以来是冠心病尤其是急性冠状动脉综合征（ACS）患者的抗栓治疗基础，但目前我国基层临床实践对指南相关推荐的依从性仍欠佳。抗血小板单片复方制剂（SPC）的开发简化了治疗方案

中文标题：

发布机构：

中国医师协会心血管内科医师分会

发布日期：

2021-06-30

简要介绍：

双联抗血小板治疗（DAPT）一直以来是冠心病尤其是急性冠状动脉综合征（ACS）患者的抗栓治疗基础，但目前我国基层临床实践对指南相关推荐的依从性仍欠佳。抗血小板单片复方制剂（SPC）的开发简化了治疗方案，便于患者管理，有望提高医师和患者对指南和处方的依从性，改善临床预后。为提高基层医师对规范抗血小板治疗的重视，更好地指导抗血小板SPC的合理使用，由中国医师协会心血管内科医师分会发起并制定了《氯吡格雷/阿司匹林单片复方制剂抗血小板治疗中国专家共识》。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=de84f1c002139229, title=氯吡格雷/阿司匹林单片复方制剂抗血小板治疗中国专家共识, enTitle=, guiderFrom=中国介入心脏病学杂志.2021.29(6):306-312., authorId=0, author=, summary=双联抗血小板治疗（DAPT）一直以来是冠心病尤其是急性冠状动脉综合征（ACS）患者的抗栓治疗基础，但目前我国基层临床实践对指南相关推荐的依从性仍欠佳。抗血小板单片复方制剂（SPC）的开发简化了治疗方案, cover=https://img.medsci.cn/2021728/1627487682639_2020535.jpg, journalId=0, articlesId=null, associationId=315, associationName=中国医师协会心血管内科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jun 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>双联抗血小板治疗（DAPT）一直以来是冠心病尤其是急性冠状动脉综合征（ACS）患者的抗栓治疗基础，但目前我国基层临床实践对指南相关推荐的依从性仍欠佳。抗血小板单片复方制剂（SPC）的开发简化了治疗方案，便于患者管理，有望提高医师和患者对指南和处方的依从性，改善临床预后。为提高基层医师对规范抗血小板治疗的重视，更好地指导抗血小板SPC的合理使用，由中国医师协会心血管内科医师分会发起并制定了《氯吡格雷/阿司匹林单片复方制剂抗血小板治疗中国专家共识》。</p> </div> </div> </div>, tagList=[TagDto(tagId=836, tagName=抗血小板)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=836, guiderKeyword=抗血小板, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12299, appHits=375, showAppHits=0, pcHits=1358, showPcHits=11923, likes=2, shares=26, comments=9, approvalStatus=1, publishedTime=Wed Jul 28 23:55:27 CST 2021, publishedTimeString=2021-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Jul 28 23:54:51 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:04:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=氯吡格雷_阿司匹林单片复方制剂抗血小板治疗中国专家共识_徐亚伟.pdf)])

氯吡格雷_阿司匹林单片复方制剂抗血小板治疗中国专家共识_徐亚伟.pdf

下载请点击：

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1203057, encodeId=fcfc120305ea8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Wed Mar 16 11:40:28 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185269, encodeId=8b0c1185269ad, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/148087fd302241c6a159d16364aac1a8/96c48a970bb14f109df8e70d4937212b.jpg, createdBy=acaa4722374, createdName=米汤, createdTime=Mon Jan 17 18:41:23 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066885, encodeId=34b81066885b9, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Nov 04 11:38:44 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062989, encodeId=b0e21062989f1, content=方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161112/IMG5826AA72364D16863.jpg, createdBy=f6d8101799, createdName=cresentt, createdTime=Fri Oct 22 17:01:06 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057567, encodeId=08c7105e56745, content=不错谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:03 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
2022-03-16 ms1000001687352890

学习

41 0
[GetPortalCommentsPageByObjectIdResponse(id=1203057, encodeId=fcfc120305ea8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Wed Mar 16 11:40:28 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185269, encodeId=8b0c1185269ad, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/148087fd302241c6a159d16364aac1a8/96c48a970bb14f109df8e70d4937212b.jpg, createdBy=acaa4722374, createdName=米汤, createdTime=Mon Jan 17 18:41:23 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066885, encodeId=34b81066885b9, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Nov 04 11:38:44 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062989, encodeId=b0e21062989f1, content=方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161112/IMG5826AA72364D16863.jpg, createdBy=f6d8101799, createdName=cresentt, createdTime=Fri Oct 22 17:01:06 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057567, encodeId=08c7105e56745, content=不错谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:03 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
2022-01-17 米汤

有用

54 0
[GetPortalCommentsPageByObjectIdResponse(id=1203057, encodeId=fcfc120305ea8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Wed Mar 16 11:40:28 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185269, encodeId=8b0c1185269ad, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/148087fd302241c6a159d16364aac1a8/96c48a970bb14f109df8e70d4937212b.jpg, createdBy=acaa4722374, createdName=米汤, createdTime=Mon Jan 17 18:41:23 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066885, encodeId=34b81066885b9, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Nov 04 11:38:44 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062989, encodeId=b0e21062989f1, content=方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161112/IMG5826AA72364D16863.jpg, createdBy=f6d8101799, createdName=cresentt, createdTime=Fri Oct 22 17:01:06 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057567, encodeId=08c7105e56745, content=不错谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:03 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
2021-11-04 huihui0728

学习#学习#

57 0
[GetPortalCommentsPageByObjectIdResponse(id=1203057, encodeId=fcfc120305ea8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Wed Mar 16 11:40:28 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185269, encodeId=8b0c1185269ad, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/148087fd302241c6a159d16364aac1a8/96c48a970bb14f109df8e70d4937212b.jpg, createdBy=acaa4722374, createdName=米汤, createdTime=Mon Jan 17 18:41:23 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066885, encodeId=34b81066885b9, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Nov 04 11:38:44 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062989, encodeId=b0e21062989f1, content=方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161112/IMG5826AA72364D16863.jpg, createdBy=f6d8101799, createdName=cresentt, createdTime=Fri Oct 22 17:01:06 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057567, encodeId=08c7105e56745, content=不错谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:03 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
2021-10-22 cresentt

方便

60 0
[GetPortalCommentsPageByObjectIdResponse(id=1203057, encodeId=fcfc120305ea8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5db65480276, createdName=ms1000001687352890, createdTime=Wed Mar 16 11:40:28 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185269, encodeId=8b0c1185269ad, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/148087fd302241c6a159d16364aac1a8/96c48a970bb14f109df8e70d4937212b.jpg, createdBy=acaa4722374, createdName=米汤, createdTime=Mon Jan 17 18:41:23 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066885, encodeId=34b81066885b9, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Thu Nov 04 11:38:44 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062989, encodeId=b0e21062989f1, content=方便, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161112/IMG5826AA72364D16863.jpg, createdBy=f6d8101799, createdName=cresentt, createdTime=Fri Oct 22 17:01:06 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057567, encodeId=08c7105e56745, content=不错谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:25:03 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
2021-10-04 H8888888

不错谢谢分享

57 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

氯吡格雷/阿司匹林单片复方制剂抗血小板治疗中国专家共识

相关指南

拓展阅读

科室

工具

服务